Stay updated on Semaglutide vs Empagliflozin Once-Daily Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page.

Latest updates to the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedUpdate the ClinicalTrials.gov page’s UI/release revision indicator from v3.5.2 to v3.5.3, without altering the underlying trial record history or the listed record versions. The content shown in the record history table remains the same.SummaryDifference0.1%

- Check16 days agoChange DetectedThe record history now shows Revision: v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedA new revision label, Revision: v3.5.0, is now shown in the Record History (replacing the previous v3.4.3).SummaryDifference0.1%

- Check52 days agoChange DetectedNew revision entry v3.4.3 added to the record history and previous revision v3.4.2 removed.SummaryDifference0.1%

- Check80 days agoChange DetectedThe history adds Revision: v3.4.2 and removes a funding-notice and an earlier Revision: v3.4.1; these updates affect only system notices and version tracking rather than study content.SummaryDifference0.9%

- Check87 days agoChange DetectedA government funding notice banner appears on the page and the Record History now shows the latest revision as v3.4.1, replacing v3.4.0 as the most recent entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Semaglutide vs Empagliflozin Once-Daily Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page.